Evidence map›Paper›PMID 36224248›Full record

ArticleCommunications biology2022

The purine metabolite inosine monophosphate accelerates myelopoiesis and acute pancreatitis progression.

Xiao-Min Luo, Sin Man Lam, Yuan Dong, Xiao-Juan Ma, Cen Yan, Yue-Jie Zhang, Yu Cao, Li Su, Guotao Lu, Jin-Kui Yang and 2 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Xiao-Min Luo *Department of Science and Development, Beijing Youan hospital, Capital Medical University, 100069, Beijing, China.
Sin Man Lam *State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, 100101, Beijing, China.ORCID 0000-0001-9037-904X
Yuan Dong *Department of Science and Development, Beijing Youan hospital, Capital Medical University, 100069, Beijing, China.
Xiao-Juan MaCenter of Basic Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, 49 North Garden Road, Haidian District, 100191, Beijing, China.
Cen YanDepartment of Science and Development, Beijing Youan hospital, Capital Medical University, 100069, Beijing, China.
Yue-Jie ZhangDepartment of Science and Development, Beijing Youan hospital, Capital Medical University, 100069, Beijing, China.
Yu CaoDepartment of Science and Development, Beijing Youan hospital, Capital Medical University, 100069, Beijing, China.
Li SuNeuroscience Research Institute, Peking University Center of Medical and Health Analysis, Peking University, 100191, Beijing, China.
Guotao LuPancreatic Center, Department of Gastroenterology, Affiliated Hospital of Yangzhou University, Yangzhou University, 225099, Yangzhou, China.
Jin-Kui YangDepartment of Endocrinology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Guanghou ShuiState Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, 100101, Beijing, China. ghshui@genetics.ac.cn.ORCID 0000-0002-1621-9643
Ying-Mei FengDepartment of Science and Development, Beijing Youan hospital, Capital Medical University, 100069, Beijing, China. yingmeif13@sina.com.ORCID 0000-0001-5248-0155
Capital Medical University · CNChinese Academy of Sciences · CNPeking University · CNBeijing Tongren Hospital · CNYangzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperglycemia-induced myelopoiesis and atherosclerotic progression occur in mice with type I diabetes. However, less is known about the effects of metabolites on myelopoesis in type 2 diabetes. Here, we use fluorescence-activated cell sorting to analyze the proliferation of granulocyte/monocyte progenitors (GMP) in db/db mice. Using targeted metabolomics, we identify an increase in inosine monophosphate (IMP) in GMP cells of 24-week-old mice. We show that IMP treatment stimulates cKit expression, ribosomal S6 activation, GMP proliferation, and Gr-1

Indexed as

Diabetes Mellitus, Type 2PancreatitisAcute DiseaseAnimalsGuanosine MonophosphateInosine MonophosphateMiceMyelopoiesisPurinesGuanosine MonophosphateInosine MonophosphatePurines

Identifiers

PMID36224248
PMCPMC9556615
OpenAlexW4304695173

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.